Nancy Lurker Insider Trading $EYPT EyePoint Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy Lurker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy Lurker. Nancy Lurker is CEO in Interpace Diagnostics Group, Inc. ($PDII) and President & CEO in pSivida Corp. ($PSDV) and President and CEO in pSivida Corp. ($PSDV) and in Aquestive Therapeutics, Inc. ($AQST) and Director in Mallinckrodt plc ($MNK).
Nancy Lurker in EyePoint Pharmaceuticals, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Nancy Lurker: President & CEO, President and CEO
Holdings: 96,579 shares
Current Value: $160,321
Latest Transaction: Feb 23 2021
$EYPT Market Capitalization: $60.15M
$EYPT Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nancy Lurker in EyePoint Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQST, EYPT, IDXG, MNK
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 13,717 | 0 | 13,718 | |
| Feb 23 2021 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 13,717 | 0 | 96,579 | 82.9 K to 96.6 K (+16.55 %) |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 124,667 | 0 | 249,333 | |
| Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 124,667 | 0 | 784,467 | 659.8 K to 784.5 K (+18.89 %) |
| Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 40,000 | 0 | 0 | |
| Jun 30 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 40,000 | 0 | 659,800 | 619.8 K to 659.8 K (+6.45 %) |
| Jun 16 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 45,000 | 0 | 45,000 | |
| Jun 16 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 45,000 | 0 | 619,800 | 574.8 K to 619.8 K (+7.83 %) |
| Mar 11 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | P | 1.06 | 98,000 | 104,027 | 574,800 | 476.8 K to 574.8 K (+20.55 %) |
| Oct 15 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Payment of Exercise | F | 2.11 | 10,745 | 22,618 | 314,455 | 325.2 K to 314.5 K (-3.30 %) |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 40,000 | 0 | 40,000 | |
| Jun 28 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 40,000 | 0 | 325,200 | 285.2 K to 325.2 K (+14.03 %) |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | A | 2.65 | 930,000 | 2,464,500 | 930,000 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | A | 2.65 | 930,000 | 2,464,500 | 930,000 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | A | 0.00 | 411,523 | 0 | 411,523 | |
| Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | A | 0.00 | 411,523 | 0 | 411,523 | |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 45,000 | 0 | 90,000 | |
| Jun 17 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 45,000 | 0 | 285,200 | 240.2 K to 285.2 K (+18.73 %) |
| Apr 01 2019 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | P | 1.76 | 28,500 | 50,246 | 240,200 | 211.7 K to 240.2 K (+13.46 %) |
| Oct 16 2018 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Grant | A | 0.00 | 76,667 | 0 | 211,700 | 135 K to 211.7 K (+56.78 %) |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 40,000 | 0 | 80,000 | |
| Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 40,000 | 0 | 135,033 | 95 K to 135 K (+42.09 %) |
| Jun 18 2018 | PSDV | EyePoint Pharmaceu ... | Lurker Nancy | President and CEO | Option Exercise | A | 2.04 | 540,000 | 1,101,600 | 540,000 | |
| Jun 18 2018 | PSDV | EyePoint Pharmaceu ... | Lurker Nancy | President and CEO | Option Exercise | A | 0.00 | 135,000 | 0 | 135,000 | |
| Mar 21 2018 | PSDV | pSivida Corp. | Lurker Nancy | President & CEO | Grant | A | 0.00 | 38,333 | 0 | 95,033 | 56.7 K to 95 K (+67.61 %) |
| Dec 19 2017 | PSDV | pSivida Corp. | Lurker Nancy | President and CEO | Option Exercise | A | 1.77 | 240,000 | 424,800 | 240,000 | |
| Dec 19 2017 | PSDV | pSivida Corp. | Lurker Nancy | President and CEO | Option Exercise | A | 0.00 | 120,000 | 0 | 120,000 | |
| Jun 14 2017 | PSDV | pSivida Corp. | Lurker Nancy | President and CEO | Buy | P | 1.76 | 56,700 | 99,962 | 56,700 | 0 to 56.7 K |
| Dec 14 2016 | PSDV | pSivida Corp. | Lurker Nancy | President and CEO | Option Exercise | A | 3.63 | 850,000 | 3,085,500 | 850,000 |
Page: 1